generics

Francesco Balestrieri appointed ad-interim CEO of Sandoz reporting directly to Vas Narasimhan, CEO, Novartis

(PRESS RELEASE) BASEL, 15-Mar-2019 — /EuropaWire/ — Sandoz's current Region Head Europe Francesco Balestrieri has just been appointed ad-interim CEO…

5 years ago

Sanofi completes the divestment of its European generics business Zentiva to Advent

PARIS, 04-Oct-2018 — /EuropaWire/ — Sanofi has completed the previously announced divestment of its European generics business Zentiva to Advent International…

6 years ago